Clinical trial Recruiting at 1 site Observational Ages 75 and up

French version validation of the New Mobility Score for older adults after hip fracture

Official title: Validation of the French Version of the New Mobility Score (NMS) in Hospitalized Patients With Hip Fracture

Run by Hospices Civils de Lyon · NCT07622095 · Data updated 2026-11-12

This study tests whether the French version of the New Mobility Score accurately measures mobility in French patients aged 75 and older after hip fracture.

Quick facts

Study typeObservational
Ages75 Years and up
SexAll
Enrollment100 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations1 site (Lyon)
StatusRecruiting
StartedAugust 27, 2026
Main results expectedFebruary 2028
Study endsMarch 2028
Registry record updatedSeptember 3, 2026
Trial IDNCT07622095 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Patients aged 75 years and older, hospitalized after hip fracture surgery (osteosynthesis or arthroplasty), fluent in French, with or without cognitive impairment (caregiver input allowed), and affiliated with health insurance.

Probably not a fit

Patients who do not complete the questionnaire or have severe cognitive impairment without caregiver support may not derive directly observable benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to validate the French translation of the New Mobility Score (NMS) in older adults who have undergone hip fracture surgery. It will assess the tool’s reliability between different raters and its ease of use in a hospital setting. Participants are 75 years or older, fluent in French, with pertrochanteric or femoral neck fractures, and able to complete questionnaires. The study focuses on implementing a quick functional assessment to support clinical practice and research in aging and mobility outcomes.

Why it matters

Potential benefit: If valid, the French NMS could provide a simple, reliable way to quickly assess mobility and guide care planning after hip fracture.

How similar studies have gone: Previous research supports the NMS in predicting outcomes, but the French version requires formal validation to confirm reliability and applicability in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 75 years and older admitted to a hospital department following a hip fracture and treated surgically (osteosynthesis or arthroplasty).
* Type of fracture: pertrochanteric fracture or femoral neck fracture.
* Sufficient proficiency in French to complete the questionnaires.
* Patients affiliated with a health insurance scheme.
* No objection to participate from the patient or the caregiver in case of cognitive impairment.

Exclusion Criteria: no exclusion criteria

Where it's running

  • Service I3 de court séjour gériatrique, Hôpital de la Croix-Rousse, Hospices Civils de Lyon
    Lyon, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.